Key Insights

Highlights

Success Rate

92% trial completion (above average)

Published Results

98 trials with published results (30%)

Research Maturity

244 completed trials (74% of total)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 27/100

Termination Rate

6.1%

20 terminated out of 328 trials

Success Rate

92.4%

+5.8% vs benchmark

Late-Stage Pipeline

18%

59 trials in Phase 3/4

Results Transparency

40%

98 of 244 completed with results

Key Signals

98 with results92% success20 terminated

Data Visualizations

Phase Distribution

255Total
Not Applicable (114)
Early P 1 (3)
P 1 (44)
P 2 (35)
P 3 (25)
P 4 (34)

Trial Status

Completed244
Recruiting21
Terminated20
Unknown17
Active Not Recruiting9
Not Yet Recruiting9

Trial Success Rate

92.4%

Benchmark: 86.6%

Based on 244 completed trials

Clinical Trials (328)

Showing 20 of 20 trials
NCT07101458Not ApplicableActive Not RecruitingPrimary

The Eswatini PRISM Study on Adolescents Living With HIV

NCT03300830RecruitingPrimary

Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease

NCT01490346CompletedPrimary

Tissue Drug Levels of HIV Medications

NCT01460433CompletedPrimary

Problems With Immune Recovery in the Gut Tissue

NCT07821671Not ApplicableNot Yet RecruitingPrimary

Improving TelePrEP Initiation and Retention Outcomes in the US: The MISTR+ Study

NCT05385484Not ApplicableActive Not RecruitingPrimary

A Savings Intervention to Reduce Men's Engagement in HIV Risk Behaviors

NCT07804602Not ApplicableNot Yet RecruitingPrimary

PositiveLinks for Youth (PL4Y) for Texas

NCT02479698Phase 2Recruiting

Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus

NCT06205511CompletedPrimary

The Prevalence of Oral HPV Infection and Oral Lesions in People Living With HIV

NCT05413811Not ApplicableCompleted

Acceptability and Feasibility of Combination Treatment for Cervical Precancer Among South African Women Living With HIV

NCT05850728Phase 1CompletedPrimary

First in Human Study of TLC-ART 101 (ACTU 2001)

NCT06651957Active Not RecruitingPrimary

Anal High-risk HPV, HSIL, and Microbiome Among Hispanic Peoples Living With HIV (PLWH)

NCT06233331Phase 1Not Yet Recruiting

Use of ACU-D1 in HPV Associated Vulvar and Perianal Lesions in People With HIV

NCT03839212Not ApplicableCompletedPrimary

The Happy Older Latinos Are Active (HOLA) Health Promotion Study in HIV-Infected Latino Men

NCT03823209Not ApplicableCompletedPrimary

Increasing PrEP Use in High-Risk Social Networks of African-American MSM in Underserved Low-Risk Cities

NCT03729778Early Phase 1Active Not Recruiting

Impact of HIV-1 and Aging on Mucosal Vaccine Responses

NCT06176859Not ApplicableCompleted

Delivery Optimization for Pre-Exposure Prophylaxis (DO PrEP) Study

NCT05404750Active Not RecruitingPrimary

Harm Reduction in HIV Primary Care for PLWH Who Use Drugs

NCT06819176Phase 1RecruitingPrimary

Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People With HIV Receiving Antiretroviral Therapy

NCT02344680CompletedPrimary

Liver Fibrosis in Zambian HIV-HBV Co-infected Patients

Scroll to load more

Research Network

Activity Timeline